Semaglutide Peptide

Semaglutide Peptide

Semaglutide is a long-acting GLP-1 (glucagon-like peptide-1) receptor agonist with a half-life of approximately one week, achieved through structural modifications including an albumin-binding fatty acid chain and amino acid substitutions that confer resistance to enzymatic degradation. It is one of the most effective appetite-suppressing and weight management peptides available.

How It Works

Semaglutide activates GLP-1 receptors (GLP-1R) across multiple tissues:

• Appetite Suppression:: Activates GLP-1R in hypothalamic nuclei and brainstem areas involved in appetite regulation, reducing food intake and promoting satiety

• Insulin Support:: Stimulates glucose-dependent insulin secretion through cAMP/PKA signaling, supporting healthy blood glucose levels

• Glucagon Suppression:: Suppresses glucagon secretion, reducing hepatic glucose output

• Gastric Emptying Delay:: Slows gastric emptying, reducing the rate of nutrient absorption and attenuating postprandial glucose excursions

• Beta-Cell Support:: Promotes beta-cell survival through PI3K/Akt and MAPK/ERK survival pathways

Key Benefits

• Powerful Appetite Suppression:: Reduces food intake and promotes sustained satiety

• Weight Management:: Supports sustainable weight loss through appetite and metabolic regulation

• Blood Sugar Support:: Promotes healthy glucose metabolism

• Long-Acting:: Once-weekly dosing profile for convenient use

Structural Properties

Semaglutide has a molecular weight of 4113.6 Da (CAS: 910463-68-2). Incorporates a C18 fatty diacid chain enabling albumin binding and extended half-life. Purity ≥98.0%.

Quality and Purity

Supplied as a lyophilized powder with purity ≥98.0% verified by HPLC and mass spectrometry. Each vial contains 5 mg.

Storage

Store at −20°C. Single-use aliquots recommended. Stable for 24 months.